Incidence Rates of Appendiceal Adenocarcinoma Increasing

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on June 16, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, June 16, 2025 -- The incidence rates of appendiceal adenocarcinoma (AA) increased after 1945, according to a study published online June 10 in the Annals of Internal Medicine.

Andreana N. Holowatyj, Ph.D., from Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues estimated the incidence rates of AA across birth cohorts in the United States in a retrospective cohort study. The study included 4,858 persons aged 20 years or older when diagnosed with pathologically confirmed primary AA (nonmucinous, mucinous, goblet cell, or signet ring cell carcinoma) from 1975 to 2019. Twenty-one overlapping birth cohorts were created using five-year age groups and time periods (1891-1899 to 1991-1999).

The researchers found that among the 1980 birth cohort, the incidence rates of AA more than tripled (incidence rate ratio [IRR], 3.41), while they quadrupled among the 1985 birth cohort (IRR, 4.62) compared with the 1945 birth cohort. Across successive birth cohorts, age-specific incidence rates of AA increased after 1945 for all tumor histological types, although to varying degrees.

"The current absence of appendiceal cancer prevention and screening methods emphasizes the importance of efforts to support earlier detection in a rare cancer where clinical trials have been historically very limited," the authors write.

Two authors disclosed ties to the pharmaceutical and biotechnology industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-06-17 06:07

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords